Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
?w=2048
'Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff Sonnenfeld and Steven Tian.